Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9J66
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,920
Award facts
- Contract value 100% obligated
- $17,919.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,919.60 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 7.5 mg/0.5 mL pen injections on November 25, 2025, with an ultimate completion date of November 26, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a broad portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The SPE2DX contract enables the company to deliver an extensive range of medications and medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Zepbound diabetes medication represents one of numerous competitively awarded transactions executed under the larger prime vehicle, demonstrating AmerisourceBergen's capability to fulfill specialized federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F9J66?
SPE2DR26F9J66 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F9J66 worth?
The government has obligated $17,920 on SPE2DR26F9J66.
Is contract SPE2DR26F9J66 an order under another contract?
Yes. SPE2DR26F9J66 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9J66 competed?
The extent of competition for SPE2DR26F9J66 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award